Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression [clinicaltrials:NCT00096798]
Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression [clinicaltrials:NCT00096798]
Bio2RDF identifier
NCT00096798
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00096798
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... acid, in treating depression.
brief title [clinicaltrials_vocabulary:brief-title]
Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2007-08-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Evidence suggests that ...... severity of their depression.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2004-11-15T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
Antidepressive Agents
Eicosapentanoic Acid
Fatty Acids, Omega-3
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2008-01-15T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00096798
official title [clinicaltrials_vocabulary:official-title]
A Double-Blind, Placebo-Contro ...... ) in Major Depressive Disorder
org study id [clinicaltrials_vocabulary:org-study-id]
K23 AT001129
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2007-08-01T00:00:00Z
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2001-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2008-01-01T00:00:00Z
identifier
clinicaltrials:NCT00096798
title
Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression
@en
type
label
Ethyl Eicosapentanoic Acid (Et ...... n [clinicaltrials:NCT00096798]
@en